Information Provided By:
Fly News Breaks for February 12, 2019
HSIC
Feb 12, 2019 | 07:55 EDT
RBC Capital analyst Stephen Hagan lowered his price target on Henry Schein to $69 to reflect his updated model after the company's animal health business spin-off. The analyst notes that the spin-off has made shares more attractive, but sees the 18-times forward earnings multiple assumed in his price target as a hurdle to a more positive rating on the shares. Hagan also keeps his Sector Perform rating on Henry Schein.
News For HSIC From the Last 2 Days
There are no results for your query HSIC